SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000093751-24-000087
Filing Date
2024-01-23
Accepted
2024-01-23 10:02:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 Allogene_The_Inc.txt SC 13G/A 6563
  Complete submission text file 0000093751-24-000087.txt   8496
Mailing Address 1 CONGRESS STREET SUITE 1 BOSTON MA 02114
Business Address 1 CONGRESS STREET SUITE 1 BOSTON MA 02114 617 786-3000
STATE STREET CORP (Filed by) CIK: 0000093751 (see all company filings)

IRS No.: 042456637 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6022 State Commercial Banks
(CF Office: 02 Finance)

Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Subject) CIK: 0001737287 (see all company filings)

IRS No.: 823562771 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90685 | Film No.: 24550750
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)